Antibiotics versus placebo for acute bacterial conjunctivitis
about
Antibiotics versus placebo for acute bacterial conjunctivitisThe safety of besifloxacin ophthalmic suspension 0.6 % used three times daily for 7 days in the treatment of bacterial conjunctivitisEvidence-based treatment of acute infective conjunctivitis: Breaking the cycle of antibiotic prescribingInterdisciplinary workshop in the philosophy of medicine: medical knowledge, medical duties.Concentrations of besifloxacin, gatifloxacin, and moxifloxacin in human conjunctiva after topical ocular administration.Knowledge and Awareness of Eye Flu among the Dentists and Dental Auxiliaries of Udaipur City, RajasthanAcute infective conjunctivitis in primary care: who needs antibiotics? An individual patient data meta-analysis.Besifloxacin, a novel fluoroquinolone, has broad-spectrum in vitro activity against aerobic and anaerobic bacteriaIntegrated analysis of three bacterial conjunctivitis trials of besifloxacin ophthalmic suspension, 0.6%: microbiological eradication outcomes.3-day treatment with azithromycin 1.5% eye drops versus 7-day treatment with tobramycin 0.3% for purulent bacterial conjunctivitis: multicentre, randomised and controlled trial in adults and children.Besifloxacin ophthalmic suspension 0.6% in the treatment of bacterial conjunctivitis patients with Pseudomonas aeruginosa infectionsCurrent pattern of antibiotic resistance of clinical isolates among conjunctival swabs.Impact of antibiotic resistance in the management of ocular infections: the role of current and future antibiotics.Relative impact of clinical evidence and over-the-counter prescribing on topical antibiotic use for acute infective conjunctivitisIntegrated analysis of three bacterial conjunctivitis trials of besifloxacin ophthalmic suspension, 0.6%: etiology of bacterial conjunctivitis and antibacterial susceptibility profile.Besifloxacin: a novel anti-infective for the treatment of bacterial conjunctivitis.Effectiveness, tolerability and safety of azithromycin 1% in DuraSite for acute bacterial conjunctivitisClinical features, outcomes, and costs of a conjunctivitis outbreak caused by the ST448 strain of Streptococcus pneumoniaeTherapeutic inferences for individual patients.Common eye infections.Spectrum of bacterial keratitis at a tertiary eye care centre in India.
P2860
Q24200694-21665DC1-9F9E-4415-B318-9DC818A45D3AQ24631812-1857E9D3-6CE3-414F-8DF8-E299A30DDBE4Q24657217-ABDC2B50-2987-4018-A9A4-F00ADFE2E0B7Q30369359-F6873F2D-2B58-4EA0-B1A9-D3E209386A98Q33819854-FE86CEC0-AF1D-4303-9E93-0291D958EF86Q34013698-09ED9842-D876-4685-8797-64E119D4EF9CQ34095093-9CBEA3EE-F281-4F04-9507-D1D638128D9FQ34608603-ECAC9A0D-F6EF-457D-94DD-BD248C3CFB20Q35410079-3A7E5A7A-EC22-4758-BFEB-7F20033D6535Q36014730-3CEA8658-2D89-4B08-89DF-96AF17FF1C01Q36451350-93EF1420-3889-411C-AC0A-6D4BFE5E358BQ37257789-E9B3EFD2-8402-4307-B5E5-8B59F52774E8Q37367643-FFEEC1F0-D712-455C-84B6-406CABDD9843Q37443704-43472241-B519-4B85-8959-58110BFA17E5Q38779535-653F93AB-CFB0-4968-A293-ACF0617E753DQ40273599-518E4281-C55C-4A71-A08C-20BBB56DBA32Q40728889-E8C7789C-D3E4-4E7C-92A6-F885B1C75527Q41185953-A2348E36-5203-4397-A98A-80388A17A4A6Q41685481-6F12F4E6-87E8-4464-B8E2-F9DE5B2C4990Q55322614-947CA090-2C01-4648-8CD6-2BA8FA84F7E9Q55631269-2847380A-E7F3-46DE-BD8D-833591477CAF
P2860
Antibiotics versus placebo for acute bacterial conjunctivitis
description
2006 nî lūn-bûn
@nan
2006 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Antibiotics versus placebo for acute bacterial conjunctivitis
@ast
Antibiotics versus placebo for acute bacterial conjunctivitis
@en
Antibiotics versus placebo for acute bacterial conjunctivitis
@en-gb
Antibiotics versus placebo for acute bacterial conjunctivitis
@nl
type
label
Antibiotics versus placebo for acute bacterial conjunctivitis
@ast
Antibiotics versus placebo for acute bacterial conjunctivitis
@en
Antibiotics versus placebo for acute bacterial conjunctivitis
@en-gb
Antibiotics versus placebo for acute bacterial conjunctivitis
@nl
prefLabel
Antibiotics versus placebo for acute bacterial conjunctivitis
@ast
Antibiotics versus placebo for acute bacterial conjunctivitis
@en
Antibiotics versus placebo for acute bacterial conjunctivitis
@en-gb
Antibiotics versus placebo for acute bacterial conjunctivitis
@nl
P2860
P1476
Antibiotics versus placebo for acute bacterial conjunctivitis
@en
P2093
Brian Hurwitz
P2860
P356
10.1002/14651858.CD001211.PUB2
P50
P577
2006-04-19T00:00:00Z